Entertainment Medical Group, Inc (Main Site, Subject Visits, IP Delivery/Storage, Regulatory, — Los Angeles, California

Entertainment Medical Group, Inc (Main Site, Subject Visits, IP Delivery/Storage, Regulatory, is a clinical research site located in Los Angeles, California, United States 90036.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Entertainment Medical Group, Inc (Main Site, Subject Visits, IP Delivery/Storage, Regulatory, has participated in 1 clinical trials.

Therapeutic areas: Ulcerative Colitis.

Sponsors: Pfizer.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Entertainment Medical Group, Inc (Main Site, Subject Visits, IP Delivery/Storage, Regulatory,?

Entertainment Medical Group, Inc (Main Site, Subject Visits, IP Delivery/Storage, Regulatory, has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Entertainment Medical Group, Inc (Main Site, Subject Visits, IP Delivery/Storage, Regulatory, conducted?

Entertainment Medical Group, Inc (Main Site, Subject Visits, IP Delivery/Storage, Regulatory, has 1 clinical trials on record. Their work covers Ulcerative Colitis.

Is Entertainment Medical Group, Inc (Main Site, Subject Visits, IP Delivery/Storage, Regulatory, accredited by Crixeo Health?

Entertainment Medical Group, Inc (Main Site, Subject Visits, IP Delivery/Storage, Regulatory, has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Entertainment Medical Group, Inc (Main Site, Subject Visits, IP Delivery/Storage, Regulatory,?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.